The cystic fibrosis transmembrane conductance regulator controls biliary epithelial inflammation and permeability by regulating Src tyrosine kinase activity

Hepatology

Volumn 64, Issue 6, 2016, Pages 2118-2134

  Fiorotto, Romina ^a,b   Villani, Ambra ^a   Kourtidis, Antonis ^c,e   Scirpo, Roberto ^a   Amenduni, Mariangela ^a   Geibel, Peter J ^d   Cadamuro, Massimiliano ^b   Spirli, Carlo ^a,b   Anastasiadis, Panos Z ^c   Strazzabosco, Mario ^a,b  

^a YALE UNIVERSITY   (United States)

^b UNIVERSITY OF MILANO BICOCCA   (Italy)

^c MAYO CLINIC   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; ENDOTOXIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN KINASE P60; TOLL LIKE RECEPTOR 4; PROTEIN TYROSINE KINASE;

ACTIN FILAMENT; ANIMAL CELL; ANIMAL MODEL; ARTICLE; BILIARY TRACT INFLAMMATION; CELL POLARITY; CHOLANGIOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; EPITHELIUM CELL; GENE MUTATION; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATORY CELL; MOUSE; NONHUMAN; PATHOGENESIS; PERMEABILITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; BILE DUCT; CELL CULTURE; CELL MEMBRANE; CYSTIC FIBROSIS; CYTOLOGY; ENZYMOLOGY; EPITHELIUM; INFLAMMATION; PHYSIOLOGY;

ANIMALS; BILE DUCTS; CELL MEMBRANE; CELLS, CULTURED; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; EPITHELIUM; INFLAMMATION; MICE; PERMEABILITY; SRC-FAMILY KINASES; TOLL-LIKE RECEPTOR 4;

EID: 84995584226     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.28817     Document Type: Article

References (47)

1. Colombo C, Battezzati PM. Liver involvement in cystic fibrosis: primary organ damage or innocent bystander? J Hepatol 2004;41:1041–1044.
2. Riordan JR, Rommens JM, Kerem B, Alon N, Rozmahel R, Grzelczak Z, et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 1989;245:1066–1073.
3. Li C, Naren AP. CFTR chloride channel in the apical compartments: spatiotemporal coupling to its interacting partners. Integr Biol (Camb) 2010;2:161–177.
4. Guggino WB. The cystic fibrosis transmembrane regulator forms macromolecular complexes with PDZ domain scaffold proteins. Proc Am Thorac Soc 2004;1:28–32.
5. Guggino WB, Stanton BA. New insights into cystic fibrosis: molecular switches that regulate CFTR. Nat Rev Mol Cell Biol 2006;7:426–436.
6. Bruscia EM, Zhang PX, Satoh A, Caputo C, Medzhitov R, Shenoy A, et al. Abnormal trafficking and degradation of TLR4 underlie the elevated inflammatory response in cystic fibrosis. J Immunol 2011;186:6990–6998.
7. Sturges NC, Wikstrom ME, Winfield KR, Gard SE, Brennan S, Sly PD, et al. Monocytes from children with clinically stable cystic fibrosis show enhanced expression of Toll-like receptor 4. Pediatr Pulmonol 2010;45:883–889.
8. John G, Yildirim AO, Rubin BK, Gruenert DC, Henke MO. TLR-4-mediated innate immunity is reduced in cystic fibrosis airway cells. Am J Respir Cell Mol Biol 2010;42:424–431.
9. Cohn JA, Strong TV, Picciotto MR, Nairn AC, Collins FS, Fitz JG. Localization of the cystic fibrosis transmembrane conductance regulator in human bile duct epithelial cells. Gastroenterology 1993;105:1857–1864.
10. Colombo C, Battezzati PM, Strazzabosco M, Podda M. Liver and biliary problems in cystic fibrosis. Semin Liver Dis 1998;18:227–235.
11. Feranchak AP, Sokol RJ. Cholangiocyte biology and cystic fibrosis liver disease. Semin Liver Dis 2001;21:471–488.
12. Strazzabosco M, Fabris L, Spirli C. Pathophysiology of cholangiopathies. J Clin Gastroenterol 2005;39:S90–S102.
13. -/- mice results in bile duct injury. Am J Physiol Gastrointest Liver Physiol 2004;287:G491–G496.
14. Fiorotto R, Scirpo R, Trauner M, Fabris L, Hoque R, Spirli C, et al. Loss of CFTR affects biliary epithelium innate immunity and causes TLR4-NF-kappaB-mediated inflammatory response in mice. Gastroenterology 2011;141:1498–1508.
15. Chattopadhyay S, Sen GC. Tyrosine phosphorylation in Toll-like receptor signaling. Cytokine Growth Factor Rev 2014;25:533–541.
16. Okutani D, Lodyga M, Han B, Liu M. Src protein tyrosine kinase family and acute inflammatory responses. Am J Physiol Lung Cell Mol Physiol 2006;291:L129–L141.
17. Medvedev AE, Piao W, Shoenfelt J, Rhee SH, Chen H, Basu S, et al. Role of TLR4 tyrosine phosphorylation in signal transduction and endotoxin tolerance. J Biol Chem 2007;282:16042–16053.
18. Chong YP, Mulhern TD, Cheng HC. C-terminal Src kinase (CSK) and CSK-homologous kinase (CHK)—endogenous negative regulators of Src-family protein kinases. Growth Factors 2005;23:233–244.
19. Ingley E. Src family kinases: regulation of their activities, levels and identification of new pathways. Biochim Biophys Acta 2008;1784:56–65.
20. Hrdinka M, Horejsi V. PAG—a multipurpose transmembrane adaptor protein. Oncogene 2014;33:4881–4892.
21. Kawabuchi M, Satomi Y, Takao T, Shimonishi Y, Nada S, Nagai K, et al. Transmembrane phosphoprotein Cbp regulates the activities of Src-family tyrosine kinases. Nature 2000;404:999–1003.
22. Bezprozvanny I, Maximov A. PDZ domains: more than just a glue. Proc Natl Acad Sci USA 2001;98:787–789.
23. Fouassier L, Duan CY, Feranchak AP, Yun CH, Sutherland E, Simon F, et al. Ezrin-radixin-moesin-binding phosphoprotein 50 is expressed at the apical membrane of rat liver epithelia. Hepatology 2001;33:166–176.
24. Moyer BD, Denton J, Karlson KH, Reynolds D, Wang S, Mickle JE, et al. A PDZ-interacting domain in CFTR is an apical membrane polarization signal. J Clin Invest 1999;104:1353–1361.
25. Snouwaert JN, Brigman KK, Latour AM, Malouf NN, Boucher RC, Smithies O, et al. An animal model for cystic fibrosis made by gene targeting. Science 1992;257:1083–1088.
26. Zeiher BG, Eichwald E, Zabner J, Smith JJ, Puga AP, McCray PB Jr, et al. A mouse model for the delta F508 allele of cystic fibrosis. J Clin Invest 1995;96:2051–2064.
27. Fiorotto R, Spirli C, Fabris L, Cadamuro M, Okolicsanyi L, Strazzabosco M. Ursodeoxycholic acid stimulates cholangiocyte fluid secretion in mice via CFTR-dependent ATP secretion. Gastroenterology 2007;133:1603–1613.
28. Spirli C, Fiorotto R, Song L, Santos-Sacchi J, Okolicsanyi L, Masier S, et al. Glibenclamide stimulates fluid secretion in rodent cholangiocytes through a cystic fibrosis transmembrane conductance regulator-independent mechanism. Gastroenterology 2005;129:220–233.
29. Spirli C, Nathanson MH, Fiorotto R, Duner E, Denson LA, Sanz JM, et al. Proinflammatory cytokines inhibit secretion in rat bile duct epithelium. Gastroenterology 2001;121:156–169.
30. Kumar S, Tana A, Shankar A. Cystic fibrosis—what are the prospects for a cure? Eur J Intern Med 2014;25:803–807.
31. Ma T, Thiagarajah JR, Yang H, Sonawane ND, Folli C, Galietta LJ, et al. Thiazolidinone CFTR inhibitor identified by high-throughput screening blocks cholera toxin-induced intestinal fluid secretion. J Clin Invest 2002;110:1651–1658.
32. McNeer NA, Anandalingam K, Fields RJ, Caputo C, Kopic S, Gupta A, et al. Nanoparticles that deliver triplex-forming peptide nucleic acid molecules correct F508del CFTR in airway epithelium. Nat Commun 2015;6:6952.
33. Scirpo R, Fiorotto R, Villani A, Amenduni M, Spirli C, Strazzabosco M. Stimulation of nuclear receptor peroxisome proliferator-activated receptor-gamma limits NF-kappaB-dependent inflammation in mouse cystic fibrosis biliary epithelium. Hepatology 2015;62:1551–1562.
34. Ivanov AI, Parkos CA, Nusrat A. Cytoskeletal regulation of epithelial barrier function during inflammation. Am J Pathol 2010;177:512–524.
35. Meng W, Takeichi M. Adherens junction: molecular architecture and regulation. Cold Spring Harb Perspect Biol 2009;1:a002899.
36. Meng F, Francis H, Glaser S, Han Y, DeMorrow S, Stokes A, et al. Role of stem cell factor and granulocyte colony-stimulating factor in remodeling during liver regeneration. Hepatology 2012;55:209–221.
37. Sansonetti PJ, Medzhitov R. Learning tolerance while fighting ignorance. Cell 2009;138:416–420.
38. Takeuchi O, Akira S. Toll-like receptors; their physiological role and signal transduction system. Int Immunopharmacol 2001;1:625–635.
39. Cohen TS, Prince A. Cystic fibrosis: a mucosal immunodeficiency syndrome. Nat Med 2012;18:509–519.
40. Fehon RG, McClatchey AI, Bretscher A. Organizing the cell cortex: the role of ERM proteins. Nat Rev Mol Cell Biol 2010;11:276–287.
41. Fouassier L, Fiorotto R. Ezrin finds its groove in cholangiocytes. Hepatology 2015;61:1467–1470.
42. Hatano R, Akiyama K, Tamura A, Hosogi S, Marunaka Y, Caplan MJ, et al. Knockdown of ezrin causes intrahepatic cholestasis by the dysregulation of bile fluidity in the bile duct epithelium. Hepatology 2015;61:1660–1671.
43. Fouassier L, Rosenberg P, Mergey M, Saubamea B, Claperon A, Kinnman N, et al. Ezrin-radixin-moesin-binding phosphoprotein (EBP50), an estrogen-inducible scaffold protein, contributes to biliary epithelial cell proliferation. Am J Pathol 2009;174:869–880.
44. Sambrotta M, Strautnieks S, Papouli E, Rushton P, Clark BE, Parry DA, et al. Mutations in TJP2 cause progressive cholestatic liver disease. Nat Genet 2014;46:326–328.
45. Lee SH. Intestinal permeability regulation by tight junction: implication on inflammatory bowel diseases. Intest Res 2015;13:11–18.
46. Baum B, Georgiou M. Dynamics of adherens junctions in epithelial establishment, maintenance, and remodeling. J Cell Biol 2011;192:907–917.
47. Aleshin A, Finn RS. SRC: a century of science brought to the clinic. Neoplasia 2010;12:599–607.